Key Market Indicators
By 2026, Israeli vaccination coverage is projected to reach 99 percent of children aged one year old. This is a 0.2 point increase from 2021, when coverage was 98 percent. The year-on-year average rate of increase since 2005 has been 0.8 points. In 2021, Israeli vaccination coverage was 99 percent of children aged one year old, one point higher than in 2020. The year-on-year average rate of increase since 1985 has been one point. Israel’s vaccine import is anticipated to rise to $105.9 million in 2026 from $90.7 million in 2021, at a compound annual growth rate of 2.7 percent. Since 2000, demand has increased by an average of 7.1 percent year on year. In 2021, Israel was ranked 36th, overtaken by Hungary with a total of $90.7 million. The United States, the United Kingdom, and Germany ranked 2nd, 3rd, and 4th in this ranking respectively. Israel’s vaccine export is forecast to expand to $18.7 million in 2026 from $16.7 million in 2021, with a year-on-year average rate of increase of 2.1 percent. Since 2001, supply has grown by an average of 32.4 percent year on year. In 2021, Israel was ranked 27th, with Brazil ahead of it at $16.7 million. Ireland, the United Kingdom, and France came in 2nd, 3rd, and 4th respectively in this ranking.
